Pencoed-based life sciences firm strikes Ł80m deal in China


Pencoed-based ReNeuron has struck an exclusive license agreement worth £80m in China for its innovative cell-based therapy treatments for strokes and blindness caused by retina disease.

A leading healthcare group in China, Fosun Pharma, will fully fund the development of ReNeuron’s CTX (stroke related treatment) and hRPC (blindness) therapy programmes in China, including clinical development and subsequent commercialisation activities.

For more information please visit

« Back to list



Forum events

Book your place
Bridgend Business Forum offers an extensive programme of exciting, inspiring and innovative events, delivered by high calibre, quality speakers. This year is no exception... there is a full and vibrant programme of events planned for the forthcoming year.

Book now >

Member to member offers

Advertise here
As a member of the Bridgend Business Forum, you have the opportunity to provide other members with information on any special offers your company has available.

Find out more >
Bridgend Business Forum Awards

This is it!
Bridgend’s greatest awards are back!

Find out more >